Interestingly, clinical evidence suggests that patients with a history of immunosuppression or receipt of immunosuppressive agents, especially TNFα inhibitors, were more likely to develop systemic Whipple’s disease with rapid deterioration directly or soon after medication onset [31–33]. The gene discussed is TNF; the disease is Whipple disease.